Larger randomized controlled trials are needed to confirm these findings and may help address concerns about indefinite therapy, lower health care costs, ease supply constraints and broaden access to GLP-1 medications to improve public health. In addition to Drs
Understanding when side effects occur, how long they last, and how to manage them effectively can make the difference between a successful treatment journey and early discontinuation
Research shows that at the highest maintenance dose of 15 mg per week, Mounjaro can help people lose up to 22.5% of their body weight over 72 weeks
In its advanced stages, it can lead to retinal detachment, optic nerve damage, and total blindness
Youll likely also experience better energy, a clearer head, improved digestion and better health long term
Retrieved March 10, 2026, from The four states that removed coverage of GLP-1 AOMs for weight loss collectively spent approximately $2.5 billion on Wegovy, Zepbound, and Saxenda in a 30-month span, on a gross basis for all indications